Home Dermatology PDF: Update on Drugs & Devices: May – June 2024
- You cannot add another "PDF: Real-World Efficacy of Azelaic Acid 15% Gel for the Reduction of Inflammatory Lesions of Rosacea" to your cart. View cart
Article
PDF: Update on Drugs & Devices: May – June 2024
$1.99
PDF Download: Update on Mavorixafor capsules (Xolremdi™), Ustekinumab-aekn SC use (Selarsdi™), Spesolimab-sbzo IV/SC use (Spevigo™), LetibotulinumtoxinA-wlbg IM use (Letybo™), and Bimekizumab SC use (Bimzelx®).
Read online:
Update on Drugs & Devices: May – June 2024
Related products
-
Article
PDF: Hydrogen Peroxide Topical Solution, 40% for the Treatment of Seborrheic Keratoses
$1.99 Add to cart -
Article
PDF: Non-Invasive Gene Expression Testing to Rule Out Melanoma
$1.99 Add to cart -
Article
PDF: Update on Drugs & Devices: September – October 2019
$1.99 Add to cart -
Article
PDF: Real-World Efficacy of Azelaic Acid 15% Gel for the Reduction of Inflammatory Lesions of Rosacea
$1.99 Add to cart
